Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

Share Price is delayed by 15 minutes
Get Live Data
3.15    0.00 (0.00%)
Bid:
3.00
Ask:
3.30
Spread: 0.30 (10.00%)
Market Cap: £13.89m
TAVI Live PriceLast checked at - London Stock Exchange

Intraday Tavistock Share Chart

Trading Update

24 Jun 2020 07:00

RNS Number : 8456Q
Tavistock Investments PLC
24 June 2020
 

Tavistock Investments Plc

("Tavistock" or the "Company")

Trading Update

24 June 2020

The Company is pleased to update the market that trading during the first two months of the financial year has been ahead of the Board's expectations. This is due both to the swift action taken to mitigate the impact of COVID-19 and the performance of the Tavistock ACUMEN Protection Portfolios.

Rapid adoption of new technology-based work practices, and implementation of business continuity plans, enabled the entire Group to move to home-based working while cost reductions were made. Voluntary salary waivers by all senior management and the significant majority of other staff, together with use of the Government's furlough scheme, mean the company has continued to trade profitably during lockdown.

The strong performance of Tavistock's ACUMEN Protection Portfolios has contributed significantly to this success. Designed specifically to shield clients from sharp and sustained falls in financial markets, they feature an automated algorithmic safeguard. If markets fall, as volatility increases, the algorithm triggers movement out of investment assets and into cash; when markets recover, as volatility decreases, the reverse is triggered, with cash being gradually reinvested into higher risk assets. These funds perform particularly well when used as a bond substitute within clients' investment portfolios.

The newest fund, the ACUMEN ESG Protection Portfolio, has performed particularly effectively since its launch on 5 December 2019, with its NAV (net asset value) having declined by less than 1%. Morgan Stanley & Co International Plc provides the ESG Protection Portfolio with its protection level, set at 90% of its NAV's highest ever value. This protection enables investors to both limit their downside exposure, and lock in 90% of performance upside.

Brian Raven, Chief Executive, said: "The performance of the ACUMEN Protection Portfolios has been exceptional, underpinning the profitability of the Group's investment management business. Our advisory business has also performed particularly well, stepping up to support clients in these challenging times and to mitigate the adverse effect that the lockdown is having on new business.

I have been enormously encouraged by the way that our entire workforce has risen to the challenges arising from the pandemic and by the widespread adoption of the Protection Portfolios to safeguard clients' personal wealth in these uncertain times.

The COVID-19 crisis triggered the biggest and fastest fall in markets since 1929 and we are now facing the worst recession in hundreds of years. Historically, viral pandemics have come in waves, so our Protection Portfolios seem to be the ideal choice right now, for the many retail clients worried about further, severe market shocks.

The Board maintains its focus on tight financial management and is confident the business will emerge from the current crisis in good shape."

Ends

Enquiries

Tavistock Investments Plc

Oliver Cooke

Brian Raven

Tel: 01753 867000

 

Arden Partners Plc

Paul Shackleton

Tel: 020 7614 5900

Allenby Capital Limited

Nick Naylor

Nick Athanas

Tel: 020 3328 5656

Vested

Sophie Paterson

Tel: 07540 496 159

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFEERSIVFII
Date   Source Headline
13th Nov 200612:57 pmRNSHolding(s) in Company
13th Nov 200612:37 pmRNSResult of EGM
19th Oct 20067:01 amRNSIssue of Equity
21st Sep 20067:00 amRNSGrant of Options
15th Sep 20067:00 amRNSHolding(s) in Company
14th Sep 20067:00 amRNSHolding(s) in Company
11th Sep 200610:29 amRNSHolding(s) in Company
8th Sep 20061:15 pmRNSLicensing Agreement
8th Sep 20061:15 pmRNSDirector Resignation
7th Sep 200610:12 amRNSStmnt re Share Price Movement
27th Jul 20065:33 pmRNSAGM Statement
26th Jul 20062:42 pmRNSHolding(s) in Company
17th Jul 20062:36 pmRNSHolding(s) in Company
13th Jul 20063:37 pmRNSHolding(s) in Company
30th Jun 20067:02 amRNSFinal Results
14th Mar 20062:58 pmRNSHolding(s) in Company
9th Mar 20063:19 pmRNSHolding(s) in Company
30th Jan 20063:57 pmRNSHolding(s) in Company
12th Jan 20067:00 amRNSTrading Statement
7th Dec 20055:12 pmRNSStatement re share price move
15th Nov 20057:12 amRNSInterim Results
7th Nov 20059:43 amRNSHolding(s) in Company
7th Nov 20057:20 amRNSTrading Statement
13th Oct 200512:03 pmRNSExercise of Option
6th Oct 20057:00 amRNSStatement re Notice of Patent
14th Sep 20057:00 amRNSTrading Update
5th Aug 20054:31 pmRNSGrant of Options
5th Aug 20054:30 pmRNSFirst Shipment of Bubble
3rd Aug 20055:22 pmRNSAGM Statement
29th Jun 20057:01 amRNSAcquisition
29th Jun 20057:01 amRNSFinal Results
12th May 20054:34 pmRNSHolding(s) in Company
29th Apr 20055:11 pmRNSHolding(s) in Company
27th Apr 20059:49 amRNSHolding(s) in Company
11th Apr 20052:18 pmRNSHolding(s) in Company
6th Apr 20054:02 pmRNSHolding(s) in Company
1st Apr 200511:11 amRNSHolding(s) in Company
31st Mar 20056:11 pmRNSHolding(s) in Company
30th Mar 20053:58 pmRNSHolding(s) in Company
24th Mar 200511:32 amRNSResult of EGM
9th Mar 20055:19 pmRNSExercise of Option
2nd Mar 20057:01 amRNSPlacing and notice of EGM
23rd Feb 200511:42 amRNSPotential Fundraising
24th Jan 20057:18 amRNSUK distribution agreement
21st Jan 20055:06 pmRNSContent Agreement with HIT
17th Jan 200511:11 amRNSStmnt re Share Price Movement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.